H.R. 2244 · 115th Congress
Patient Experience in Research Act of 2017
- Stage
- In committee
- Sponsor
- Leonard Lance
- Introduced
- 2017-04-28
- Latest action
- 2017-05-05 · Referred to the Subcommittee on Health.
Summary
Patient Experience in Research Act of 2017
This bill requires the Food and Drug Administration to carry out a pilot project under which sponsors of new drugs or biological products agree to evaluate: (1) the distress experienced by patients in clinical trials for medications intended to treat a serious condition, and (2) the effects of providing support to distressed patients on the outcome of a clinical trial. The user fee is waived for new drug applications that include data from such an evaluation.